Literature DB >> 404376

Thyrotrophin releasing hormone-induced growth hormone and prolactin release: physiological studies in intact rats and in hypophysectomized rats bearing an ectopic pituitary gland.

A E Panerai, I Gil-Ad, D Cocchi, V Locatelli, G L Rossi, E E Müller.   

Abstract

To determine how the sensitivity of the ectopic anterior pituitary gland to the GH-releasing effect of thyrotrophin releasing hormone (TRH) might be affected by the time lapse from transplantation, TRH (0-15 and 0-6 microng) was injected i.v. into hypophysectomized (hypox)-transplanted rats under urethane anaesthesia 1,3,8,15,30 and 60 days after transplantation, and plasma samples were taken 5 and 10 min later. Baseline GH values gradually decreased with time from about 16-0 ng/ml (1 day) to about 3-0 ng/ml (30 and 60 days). The TRH-induced GH release was absent 1 day after transplantation, present only with the higher TRH dose 3 and 8 days after transplantation, and clearly elicitable, also with the lower TRH dose (0-15 microng), from 15 up to 60 days. Determination of plasma prolactin concentrations showed a decline from about 85-0 ng/ml (1 day) to about 32-0 ng/ml (8 days); subsequently (15-60 days) prolactin values stabilized. Plasma prolactin levels increased 15 and 60 days after transplantation only when a dose of 0-6 microng TRH was given. In intact weight-matched rats, TRH induced a GH response only at the dose of 1-2 microng while a short-lived but clear-cut prolactin response could be obtained even with the 0-3 microng dose. The present results indicate that: (1) disconnexion between the central nervous system and the anterior pituitary gland greatly enhances GH responsiveness while blunting prolactin responsiveness to TRH; (2) the sensitivity of the anterior pituitary gland to the GH-releasing effect of TRH increases with time from transplantation; (3) TRH is a more effective prolactin- than GH-releaser on the pituitary gland in situ.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 404376     DOI: 10.1677/joe.0.0720301

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  5 in total

1.  Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production.

Authors:  K Flurkey; J Papaconstantinou; R A Miller; D E Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

Review 2.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

3.  Growth hormone responses to oral glucose and intravenous thyrotropin-releasing hormone in acromegalic patients treated by slow-release lanreotide.

Authors:  J J Díez; P Iglesias; A Gómez-Pan
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

4.  Suppression of clonidine-induced release of growth hormone by thyrotropin releasing hormone in humans.

Authors:  A Zanoboni; W Zanoboni-Muciaccia; C Zanussi; R Baraldi
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

5.  Somatic growth in hypophysectomized pituitary-homografted rats is promoted by prolactin.

Authors:  F Drago; G Continella
Journal:  Experientia       Date:  1985-11-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.